In contrast to this study, Kittang et al. demonstrated that MDS patients display higher IL-6 production compared to healthy donors, but the authors did not find any correlation between IL-6 levels and progression to AML [93]. This evidence concerns the gene IL6 and acute myeloid leukemia.